- Home
- KBDC vs OMCL Comparison
KBDC vs OMCL Comparison
Compare KBDC & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBDC
- OMCL
- Stock Information
- Founded
- KBDC 2021
- OMCL 1992
- Country
- KBDC United States
- OMCL United States
- Employees
- KBDC N/A
- OMCL N/A
- Industry
- KBDC
- OMCL Computer Manufacturing
- Sector
- KBDC
- OMCL Technology
- Exchange
- KBDC Nasdaq
- OMCL Nasdaq
- Market Cap
- KBDC 1.2B
- OMCL 1.3B
- IPO Year
- KBDC N/A
- OMCL 2001
- Fundamental
- Price
- KBDC $15.90
- OMCL $28.03
- Analyst Decision
- KBDC Buy
- OMCL Buy
- Analyst Count
- KBDC 5
- OMCL 6
- Target Price
- KBDC $16.60
- OMCL $44.83
- AVG Volume (30 Days)
- KBDC 109.6K
- OMCL 550.7K
- Earning Date
- KBDC 08-12-2025
- OMCL 07-31-2025
- Dividend Yield
- KBDC 11.99%
- OMCL N/A
- EPS Growth
- KBDC N/A
- OMCL N/A
- EPS
- KBDC N/A
- OMCL 0.45
- Revenue
- KBDC N/A
- OMCL $1,135,755,000.00
- Revenue This Year
- KBDC $193.84
- OMCL $3.84
- Revenue Next Year
- KBDC $12.68
- OMCL $4.07
- P/E Ratio
- KBDC N/A
- OMCL $61.95
- Revenue Growth
- KBDC N/A
- OMCL 3.00
- 52 Week Low
- KBDC $13.93
- OMCL $22.66
- 52 Week High
- KBDC $17.99
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- KBDC N/A
- OMCL 39.02
- Support Level
- KBDC N/A
- OMCL $30.73
- Resistance Level
- KBDC N/A
- OMCL $32.05
- Average True Range (ATR)
- KBDC 0.00
- OMCL 0.76
- MACD
- KBDC 0.00
- OMCL -0.26
- Stochastic Oscillator
- KBDC 0.00
- OMCL 0.99
About KBDC Kayne Anderson BDC Inc. Common Stock
Kayne Anderson BDC Inc is a business development company that invests primarily in first-lien senior secured loans, with a secondary focus on unitranche and split-lien loans to middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation primarily through debt investments in middle-market companies.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.